This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Araujo, A. B. Articles by McKinlay, J. B. Search for Related Content PubMed PubMed Citation Articles by Araujo, A. B. Articles by McKinlay, J. B. Related Collections Calcium and Bone Metabolism Male Endocrinology

Correlations between Serum Testosterone, Estradiol, and Sex Hormone-Binding Globulin and Bone Mineral Density in a Diverse Sample of Men

New England Research Institutes, Incorporated (A.B.A., T.G.T., J.B.M.), Watertown, Massachusetts 02472; and Endocrine Unit (B.Z.L.), Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114

Address all correspondence to: Andre B. Araujo, Ph.D., Research Scientist, New England Research Institutes, 9 Galen Street, Watertown, Massachusetts 02472. E-mail: aaraujo{at}neriscience.com. Address requests for reprints to: John B. McKinlay, Ph.D., Senior Vice President, New England Research Institutes, 9 Galen Street, Watertown, Massachusetts 02472. E-mail: bachbone{at}neriscience.com.

Context: The relationship between hormones and bone mineral density (BMD) in men has received considerable attention. However, most studies have been conducted in homogenous populations, and it is not known whether differences in hormones impact racial and ethnic differences in BMD.

Objective: Our objective was to examine associations of testosterone, estradiol, and sex hormone-binding globulin (SHBG) with BMD in a racially and ethnically diverse population.

Design: This was a population-based, observational survey.

Participants: A total of 976 Black, Hispanic, and white randomly selected men ages 30–79 yr from the Boston Area Community Health/Bone Survey were included.

Outcome: BMD at the hip, wrist, and spine were calculated.

Results: The mean age of the sample was 46.7 ± 12.4 yr. BMD levels were highest in black men, followed by Hispanic and then white men. Associations between hormones and BMD were consistent across racial and ethnic groups. Total and free testosterone was not correlated with BMD in age- or multivariate-adjusted models. SHBG was inversely correlated with total hip and ultradistal radius BMD after age adjustment, but not with multivariate adjustment for age, lean mass, fat mass, physical activity, self-rated health, and smoking. Total and free estradiol levels were positively and significantly correlated with femoral neck and total hip BMD, even with multivariate adjustment (partial correlations ranged between 0.11 and 0.16). However, estradiol levels failed to account for racial and ethnic differences in hip BMD.

Conclusions: In our diverse population, neither serum total nor free testosterone levels were associated with BMD. Correlations between BMD and estradiol were significant but did not appear to account for any of the observed racial and ethnic differences in BMD. These findings suggest that differences in hormone levels are not a major contributor to the observed differences in BMD between Black, Hispanic, and white men.

This article has been cited by other articles:

				C. Ohlsson and L. Vandenput The role of estrogens for male bone health Eur. J. Endocrinol., June 1, 2009; 160(6): 883 - 889. [Abstract] [Full Text] [PDF]

				T. G. Travison, A. B. Araujo, T. J. Beck, R. E. Williams, R. V. Clark, B. Z. Leder, and J. B. McKinlay Relation between Serum Testosterone, Serum Estradiol, Sex Hormone-Binding Globulin, and Geometrical Measures of Adult Male Proximal Femur Strength J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 853 - 860. [Abstract] [Full Text] [PDF]

				S. A. Hall, A. B. Araujo, T. G. Travison, G. R. Esche, J. B. McKinlay, R. V. Clark, and R. E. Williams Men, Androgen Deficiency, and Pharmaceutical Promotion--Reply Arch Intern Med, January 12, 2009; 169(1): 88 - 89. [Full Text] [PDF]